Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02497430 · ClinicalTrials.gov registry record
Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay
A clinical trial of Pregnancy and GBS, sponsored by Luminex Corporation.
- Completed
- Registry status
- 918
- Enrollment target
- 5
- Study locations
NCT02497430 is a study of Pregnancy and GBS that has completed, run by Luminex Corporation. The registered enrollment target is 918 participants, roughly in line with the 868-participant average among 191 other Pregnancy trials with a reported enrollment target. The trial reports 5 study locations across 5 states.
The verdict
NCT02497430, a study of Pregnancy and GBS, has completed, sponsored by Luminex Corporation.
- COMPLETED
- Registry status
- 918 participants
- Enrollment target
- 5
- Study locations
Study Summary
The ARIES GBS Assay is a real-time PCR based qualitative test designed to detect Group B Streptococcus (GBS) nucleic acid from Lim Broth enriched vaginal-rectal specimen swabs obtained from pregnant women between 35 - 37 weeks gestation.
Study Locations (5)
Florida
- Sacred Heart Health System - Pensacola
Michigan
- Detroit Medical Center University Laboratories - Detroit
New Mexico
- TriCore Reference Laboratories - Albuquerque
Pennsylvania
- Geisinger Medical Laboratories - Danville
Texas
- Baylor Scott & White - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 918 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02497430
The ClinicalTrials.gov registry entry for NCT02497430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 918 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 868-participant average among 191 other Pregnancy trials with a reported enrollment target. The listed sponsor is Luminex Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT02497430 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Michigan, New Mexico.
Frequently Asked Questions
What is clinical trial NCT02497430 about?
NCT02497430 is a clinical study titled "Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay". The ARIES GBS Assay is a real-time PCR based qualitative test designed to detect Group B Streptococcus (GBS) nucleic acid from Lim Broth enriched vaginal-rectal specimen swabs obtained from pregnant women between 35 - 37 weeks gestation.
What is the current status of trial NCT02497430?
This trial is currently completed. The enrollment target is 918 participants. The study started on 2016-03. Estimated completion is 2016-08.
What conditions does trial NCT02497430 study?
This clinical trial studies the following conditions: Pregnancy, GBS.
Who is sponsoring clinical trial NCT02497430?
This trial is sponsored by Luminex Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02497430 being conducted?
This trial has 5 study locations across Florida, Michigan, New Mexico, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.